Warning: The NCBI web site requires JavaScript to function. more...
Drug use and opioid substitution treatment for prisoners.
Stöver H, Michels II.
Harm Reduct J. 2010 Jul 19;7:17.
Related citations
[Guidelines for substitution treatments in prison populations].
Michel L, Maguet O.
Encephale. 2005 Jan-Feb;31(1 Pt 1):92-7. French.
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
Larney S, Dolan K.
Eur Addict Res. 2009;15(2):107-12. Epub 2009 Feb 2. Review.
Initiation of opiate addiction in a Canadian prison: a case report.
Wood E, Lim R, Kerr T.
Harm Reduct J. 2006 Mar 16;3:11.
Interventions to reduce HIV transmission related to injecting drug use in prison.
Jürgens R, Ball A, Verster A.
Lancet Infect Dis. 2009 Jan;9(1):57-66. Review.
Harm reduction and equity of access to care for French prisoners: a review.
Michel L, Carrieri MP, Wodak A.
Harm Reduct J. 2008 May 21;5:17.
Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
Larney S.
Addiction. 2010 Feb;105(2):216-23. Review.
HIV risk behaviour correlates among injecting drug users in Greek prisons.
Koulierakis G, Gnardellis C, Agrafiotis D, Power KG.
Addiction. 2000 Aug;95(8):1207-16.
Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.
Bird AG, Gore SM, Cameron S, Ross AJ, Goldberg DJ.
AIDS. 1995 Jul;9(7):801-8.
Substitution treatment for opioid addicts in Germany.
Michels II, Stöver H, Gerlach R.
Harm Reduct J. 2007 Feb 2;4:5.
Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff.
Gjersing LR, Butler T, Caplehorn JR, Belcher JM, Matthews R.
Drug Alcohol Rev. 2007 Sep;26(5):501-8.
Indonesian prisons and HIV: part of the problem, part of the solution?
Nelwan EJ, Diana A, van Crevel R, Alam NN, Alisjahbana B, Pohan HT, van der Ven A, Djaya I.
Acta Med Indones. 2009 Jul;41 Suppl 1:52-6.
The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.
Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.
Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C, Guy JM, Parkes J, Roderick P, Rosenberg WM.
Gut. 2003 Oct;52(10):1500-4.
Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study.
Rotily M, Weilandt C, Bird SM, Käll K, Van Haastrecht HJ, Iandolo E, Rousseau S.
Eur J Public Health. 2001 Sep;11(3):243-50.
HIV/AIDS behind bars.
MacDougall DS.
J Int Assoc Physicians AIDS Care. 1998 Apr;4(4):8-13.
Drug use and initiation in prison: results from a national prison survey in England and Wales.
Boys A, Farrell M, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Marsden J, Meltzer H, Singleton N, Taylor C.
Addiction. 2002 Dec;97(12):1551-60.
Social characteristics, HIV/AIDS knowledge, preventive practices and risk factors elicitation among prisoners in Lagos, Nigeria.
Odujinrin MT, Adebajo SB.
West Afr J Med. 2001 Jul-Sep;20(3):191-8.
Tobacco in prisons: a focus group study.
Richmond R, Butler T, Wilhelm K, Wodak A, Cunningham M, Anderson I.
Tob Control. 2009 Jun;18(3):176-82. Epub 2009 Feb 2.
Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.
Zamani S, Farnia M, Torknejad A, Alaei BA, Gholizadeh M, Kasraee F, Ono-Kihara M, Oba K, Kihara M.
J Urban Health. 2010 Jul;87(4):603-16.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on